Dietary factors influence production of the soy isoflavone metabolite S-(-)equolin healthy adults

Journal of Nutrition

Volumn 143, Issue 12, 2013, Pages 1950-1958

  Setchell, Kenneth D ^a,e   Brown, Nadine M ^a   Summer, Suzanne ^b   King, Eileen C ^c   Heubi, James E ^b,d,e   Cole, Sidney ^f   Guy, Trish ^f   Hokin, Bevan ^g  

^a Divisions of Clinical Mass Spectrometry   (United States)

^b Division of Clinical Translational Research Center   (United States)

^c Division of Biostatistics and Epidemiology   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f Sanitarium Health and Wellbeing   (Australia)

^g SYDNEY ADVENTIST HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; DAIDZEIN; DISACCHARIDE; EQUOL; FAT; MALTOSE; METRONIDAZOLE; MONOSACCHARIDE; POLYUNSATURATED FATTY ACID; PROTEIN; RETINOL; SATURATED FATTY ACID; TRACE ELEMENT; VEGETABLE PROTEIN; VITAMIN B GROUP; VITAMIN D; VITAMIN K GROUP; ANTIINFECTIVE AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; AUSTRALIA; BODY MASS; CALORIC INTAKE; CAUCASIAN; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; MACRONUTRIENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OMNIVORE; PROTEIN DIET; PROTEIN INTAKE; SOYBEAN; SOYBEAN MILK; UNITED STATES; URINALYSIS; VEGETARIAN; VITAMIN INTAKE; BIOSYNTHESIS; COHORT ANALYSIS; DIET; MIDDLE AGED; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DIET; EQUOL; FEMALE; HUMANS; MALE; MIDDLE AGED; SOY MILK; YOUNG ADULT;

EID: 84888395204     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.179564     Document Type: Article

References (65)

1. Setchell KDR, Clerici C. Equol: history, chemistry, and formation. J Nutr. 2010; 140:S1355-62.
2. Setchell KDR, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr. 2010; 140:S1363-8.
3. Yee S, Burdock GA, Kurata Y, Enomoto Y, Narumi K, Hamada S, Itoh T, Shimomura Y, Ueno T. Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lacto-coccus garvieae. Food Chem Toxicol. 2008; 46:2713-20.
4. Setchell KDR, Zhao X, Shoaf SE, Ragland K. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr. 2009; 139:2037-43.
5. Schwen RJ, Nguyen L, Plomley JB, Jackson RL. Toxicokinetics and lack of uterotropic effect of orally administered S-equol. Food Chem Toxicol. 2012; 50:1741-8.
6. Setchell KDR, Cole SJ. Method of defining equol-producer status and its frequency among vegetarians. J Nutr. 2006; 136:2188-93.
7. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet. 1997; 350:23-7.
8. Setchell KDR, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Zimmer-Nechemias L, Brown NM, Lund TD, et al. S-(-) equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005; 81:1072-9.
9. Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984; 40:569-78.
10. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med. 1998; 217:335-9.
11. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer. 2000; 36:27-32.
12. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, Mazur W, Wähälä K, Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998; 128:1710-5.
13. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, Watanabe S. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000; 10:127-35.
14. Akaza H, Miyanaga N, Takahima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim W-J, Song JM, et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004; 34:86-9.
15. Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wähälä K, Thomas WK, Lampe JW. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006; 136:1347-51.
16. Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Park JK, Kim SS, Kim Y. Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr. 2012; 7:567-74.
17. Setchell KDR, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002; 132:3577-84.
18. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr. 2009;89:S1664-7.
19. Jackson RL, Greiwe JS, Schwen RJ. Emerging evidence of the health benefits of S-equol, an estrogen receptor beta agonist. Nutr Rev. 2011; 69:432-48.
20. Lampe JW, Skor HE, Li S, Wähälä K, Howald WN, Chen C. Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavone equol in premenopausal women. J Nutr. 2001; 131:740-4.
21. Lydeking-Olsen E, Beck-Jensen JE, Setchell KDR, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss: a 2 year randomized, placebo-controlled trial. Eur J Nutr. 2004; 43:246-57.
22. Bolca S, Possemiers S, Herregat A, Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De Keukeleire K, Bracke M, et al. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr. 2007; 137:2242-6.
23. Gardana C, Canzi E, Simonetti P. The role of diet in the metabolism of daidzein by human faecal microbiota sampled from Italian volunteers. J Nutr Biochem. 2009; 20:940-7.
24. Hanna KL, O'Neill S, Lyons-Wall PM. Intake of isoflavone and lignan phytoestrogens and associated demographic and lifestyle factors in older Australian women. Asia Pac J Clin Nutr. 2010; 19:540-9.
25. Lundh T. Metabolism of estrogenic isoflavones in domestic animals. Proc Soc Exp Biol Med. 1995; 208:33-9.
26. Gu L, House SE, Prior RL, Fang N, Ronis MJ, Clarkson TB, Wilson ME, Badger TM. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr. 2006; 136:1215-21.
27. Setchell KDR, Brown NM, Zhao X, Lindley SL, Heubi JE, King EC, Messina M. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr. 2011; 94:1284-94.
28. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood). 2005; 230:155-70.
29. Niculescu MD, Pop EA, Fischer LM, Zeisel SH. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem. 2007; 18:380-90.
30. Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull. 2001; 24:351-6.
31. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004; 12:1559-67.
32. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biol Reprod. 2004; 70:1188-95.
33. Nagata C, Ueno T, Uchiyama S, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women. Nutr Cancer. 2008; 60:49-54.
34. Tamura A, Shiomi T, Hachiya S, Shigematsu N, Hara H. Low activities of intestinal lactase suppress the early phase absorption of soy isoflavones in Japanese adults. Clin Nutr. 2008; 27:248-53.
35. Miyanaga N, Akaza H, Takashima N, Nagata Y, Sonoda T, Mori M, Naito S, Hirao Y, Tsukamoto T, Fujioka T. Higher consumption of green tea may enhance equol production. Asian Pac J Cancer Prev. 2003; 4:297-301.
36. Teas J, Hurley TG, Hebert JR, Franke AA, Sepkovic DW, Kurzer MS. Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women. J Nutr. 2009; 139:939-44.
37. Védrine N, Mathey J, Morand C, Brandolini M, Davicco MJ, Guy L, Remesy C, Coxan V, Manach C. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr. 2006;160:1039-45.
38. Sugiyama Y, Masumori N, Fukuta F, Yoneta A, Hida T, Yamashita T, Minatoya M, Nagata Y, Mori M, Tsuji H, et al. Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev. 2013; 14:1-4.
39. Messina M, Nagata C, Wu AH. Estimated asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006; 55:1-12.
40. Valentín-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB. Urinary phytoestrogen concentrations in the U.S. population (1999-2000). J Expo Anal Environ Epidemiol. 2005; 15:509-23.
41. Peeters PH, Slimani N, van der Schouw YT, Grace PB, Navarro C, Tjonneland A, Olsen A, Clavel-Chapelon F, Touillaud M, Boutron-Ruau MC, et al. Variations in plasma phytoestrogen concentrations in European adults. J Nutr. 2007; 137:1294-300.
42. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res. 2008; 10:R32.
43. Travis RC, Spencer EA, Allen NE, Appleby PN, Roddam AW, Overvad K, Johnsen NF, Olsen A, Kaaks R, Linseisen J, et al. Plasma phyto-oestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer. 2009; 100:1817-23.
44. Goodman MT, Shvetsov YB, Wilkens LR, Franke AA, Le Marchand L, Kakazu KK, Nomura AM, Henderson BE, Kolonel LN. Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study. Cancer Prev Res (Phila). 2009; 2:887-94.
45. Franke AA, Lai JF, Pagano I, Morimoto Y, Maskarinec G. Equol production changes over time in pre-menopausal women. BritJ Nutr. 2012; 107:1201-6.
46. Davis CD, Milner JA. Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem. 2009; 20:743-52.
47. Floch MH. Intestinal microecology in health and wellness. J Clin Gastroenterol. 2011; 45 Suppl:S108-10.
48. Decroos K, Vanhemmens S, Cattoir S, Boon N, Verstraete W. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions. Arch Microbiol. 2005; 183:45-55.
49. Minamida K, Tanaka M, Abe A, Sone T, Tomita F, Hara H, Asano K. Production of equol from daidzein by gram-positive rod-shaped bacterium isolated from rat intestine. J Biosci Bioeng. 2006; 102:247-50.
50. Fortina MG, Ricci G, Foschino R, Picozzi C, Dolci P, Zeppa G, Cocolin L, Manachini PL. Phenotypic typing, technological properties and safety aspects of Lactococcus garvieae strains from dairy environments. J Appl Microbiol. 2007; 103:445-53.
51. Reissbrodt R, Kemmer G, Seltmann G. Abhangigkeit der Ausbildung bestimmter Antigene von Proteus mirabilis Stamm 1095/67 beim Wachstrum auf Minimalnahrmedien. Z Allg Mikrobiol. 1975; 15:357-70.
52. Lopez RL, Garcia MT, Abriouel H, Ben Omar N, Grande MJ, Martinez-Canamero M, Galvez A. Semi-preparative scale purification of enterococcal bacteriocin enterocin EJ97, and evaluation of substrates for its production. J Ind Microbiol Biotechnol. 2007; 34:779-85.
53. Masurekar PS. Nutritional and engineering aspects of microbial process development. Prog Drug Res. 2008; 65:291, 3-328.
54. Terrade N, Mira de Orduna R. Determination of the essential nutrient requirements of wine-related bacteria from the genera Oenococcus and Lactobacillus. Int J Food Microbiol. 2009; 133:8-13.
55. Frankenfeld CL, Atkinson C, Thomas WK, Goode EL, Gonzalez A, Jokela T, Wähälä K, Schwartz SM, Li SS, Lampe JW. Familial correlations, segregation analysis, and nongenetic correlates of soy isoflavone-metabolizing phenotypes. Exp Biol Med (Maywood). 2004; 229:902-13.
56. Franke AA, Lai JF, Halm BM, Pagano I, Kono N, Mack WJ, Hodis HN. Equol production changes over time in postmenopausal women. J Nutr Biochem. 2012; 23:573-9.
57. Blair RM, Appt SE, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicu-laris). J Nutr. 2003; 133:2262-7.
58. Atkinson C, Berman S, Humbert O, Lampe JW. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr. 2004; 134:596-9.
59. Setchell KDR, Lawson AM, Borriello SP, Harkness R, Gordon H, Morgan DM, Kirk DN, Adlercreutz H, Anderson LC, Axelson M. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet. 1981; 2:4-7.
60. Uehara M, Ohta A, Sakai K, Suzuki K, Watanabe S, Adlercreutz H. Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinary excretion and kinetics in blood of rats. J Nutr. 2001; 131:787-95.
61. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercreutz H, Kurzer MS. Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr. 2004; 134:1998-2003. PubMed 62. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr. 2004;134:3277-83.
62. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr. 2004;134:3277-83.
63. Bonorden MJ, Greany KA, Wangen KE, Phipps WR, Feirtag J, Adlercreutz H, Kurzer MS. Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women. Eur J Clin Nutr. 2004; 58:1635-42.
64. Clerici C, Setchell KDR, Battezzati PM, Pirro M, Giuliano V, Asciutti S, Castellani D, Nardi E, Sabatino G, Orlandi S, et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr. 2007; 137:2270-8.
65. Clerici C, Nardi E, Battezzati PM, Asciutti S, Castellani D, Corazzi N, Giuliano V, Gizzi S, Perriello G, Di Matteo G, et al. Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes. Diabetes Care. 2011; 34:1946-8.